THE QT INTERVAL AND DRUG-ASSOCIATED TORSADES-DE-POINTES

被引:41
作者
BENEDICT, CR
机构
[1] Division of Cardiology, The University of Texas Medical School, Houston, Texas
来源
DRUG INVESTIGATION | 1993年 / 5卷 / 01期
关键词
D O I
10.1007/BF03259230
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Torsades de pointes is an uncommon form of ventricular tachyarrhythmia, which may occur in the presence or absence of drug therapy. There are several difficulties in establishing a relationship between drug therapy and the induction of this arrhythmia. Drugs for which a definitive association with torsades de pointes are established, i.e. class IA and III antiarrhythmics, are known to prolong the QT or QT(c) interval. However, the definition of significant QT or QT(c) prolongation is sometimes difficult because there is a significant inter- and intrapatient variability in the observed QT or QT(c) interval even in the absence of drug therapy. Furthermore, some drugs that induce prolongation of the QT or QT(c) interval in a given patient do not precipitate torsades de pointes. Recent reports of unexpected drug-induced torsades de pointes by drugs other than class IA or III antiarrhythmics led to the examination of the association between QT interval prolongation and torsades de pointes, and evaluation of the mechanisms for drug-induced torsades de pointes by drugs other than class IA or III antiarrhythmic drugs.
引用
收藏
页码:69 / 79
页数:11
相关论文
共 82 条
  • [11] Cassem N., Cardiovascular effects of antidepressant drugs, Journal of Clinical Psychology, 43, pp. 22-28, (1982)
  • [12] Clark M., Lazzara R., Jackman W.M., Torsades de pointes: serum drug levels and ECG warning signs, Circulation, 66, pp. 11-71, (1982)
  • [13] Coumel P., Leclercq J.F., Lucet V., Possible mechanisms of the arrhythmias in the long QT syndrome, European Heart Journal, 6, (1985)
  • [14] Craft T.M., Torsades de pointes after astemizole overdose, British Medical Journal, 292, (1986)
  • [15] Davidowski T.A., Wolf S., The QT interval during reflex cardiovascular adaptation, Circulation, 69, pp. 22-25, (1984)
  • [16] Davies A.J., Harindra V., McEwan A., Et al., Cardiotoxic effect with convulsions in terfenadine overdose, British Medical Journal, 298, (1989)
  • [17] Denes P., Gabster A., Huang S.K., Clinical, electrocardiographic and follow-up observations in patients having ventricular fibrillation during Holter monitoring. Role of quinidine therapy, American Journal of Cardiology, 48, pp. 9-15, (1981)
  • [18] Dessertenne F., Considerations sur l’electrocardiogramme de la fibrillation ventriculaire, Archives des Maladies du Coeur, 59, pp. 1421-1437, (1966)
  • [19] Dressler W., Observations in patients with implanted pacemaker. III. Frequency of ventricular tachycardia as cause of Adams-Stokes attacks and rate of pacing required for it prevention, American Heart Journal, 68, pp. 19-24, (1964)
  • [20] Duny P.F., Liozon F., Goudoud J.C., Et al., Torsades de pointes et arythmies ventriculaires graves par administration parenterale de vincamine, Archives des Maladies du Coeur, 73, pp. 298-306, (1980)